Matthew Autterson is both the president and chief executive officer of CNS Biosciences, Inc., a company that was established in 2013. His company was founded by Dr. Scott Falci and it is a biotechnology company which specializes in neuropathic pain drugs. Its clinical research is in both early-stage and clinical stage drug development. Their goal is to help those with neuromotor disabilities both interact with and control their environment leading to better quality lives.
For several years Matthew Autterson was the managing partner of GL3B Partners Limited, LLP which invests in marketable securities, privately held companies, and real estate. He was with this company for over 16 years and was highly successful in developing partnership assets during his time here. For 19 and a half years prior to this he was with Resources Trust Company and became the company’s president in 1986. Like the other companies he has worked with this company is located in the state of Colorado. During his time with this company it underwent a series of acquisitions and for a time it was called SunAmerica. Eventually, SunAmerica was acquired by the giant financial firm AIG in 1998 in a $18 billion deal.
Matthew Autterson is a graduate of Michigan State University and earned his bachelor’s degree in finance and general business in 1979. He also attended the University of Denver and graduated from their tax program. After graduating he started his professional career at First Trust Corporation and left after three years in order to join the company that eventually was named Resources Trust Company.
In addition to his role at CNS Biosciences, Matthew Auterson sits on the Board of Directors for Falci Adaptive Biosystems. He has also been on a number of nonprofits boards including the Denver Zoo, the Webb-Waring Foundation, the Denver Zoological Foundation, and Denver Hospice. In the past he was members of both the World Presidents Organization and the Young Presidents Organization.
One of the nonprofit that Matthew Autterson has been most involved with over the years is the Denver Zoo. For 10 years he was both on their board and served as the vice chairman of finance for this organization, lending his extensive experience in this field. He was also involved with The Denver Hospice for 15 years during which time he was heavily involved in their mission to help those who find themselves needing hospice care.